Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
21
result was found. Results that relate to
Rapid health technology assessment
Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1156-1163.
4283 times
729 times
HUANG Gerile
LI Yujie
ZHANG Wenjing
GUO Hao
Efgartigimod alfa
Myasthenia gravis
Rapid health technology assessment
Efficaey
Safety
Economy
Details
Tofacitinib for the treatment of ulcerative colitis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(12):1414-1424.
9460 times
617 times
LI Huiling
DUAN Yinyin
LI Qianqian
WU Xiaoli
Tofacitinib
Ulcerative colitis
Rapid health technology assessment
Details
Vonoprazan for ulcers associated with endoscopic submucosal dissection: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(3):306-313.
3387 times
560 times
WANG Wei
KE Yijun
CHENG Chang
FANG Chongwen
PAN Lisheng
JIN Yong
ZHANG Yanping
Vonoprazan
Endoscopic submucosal dissection
Ulcer
Rapid health technology assessment
Details
Venetoclax in the treatment of non-M3 acute myeloid leukemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(3):314-323.
2966 times
497 times
ZHANG Yazhuo
LI Huiling
Duan Yinyin
SHI Yuye
Venetoclax
Non-M3 acute myeloid leukemia
Rapid health technology assessment
Details
Dorzagliatin in the treatment of type 2 diabetes：a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(4):448-455.
4406 times
1694 times
LI Yujie
ZHANG Wenjing
YANG Hongxin
GUO Hao
Dorzagliatin
Type 2 diabetes mellitus
Rapid health technology assessment
Efficacy
Safety
Economy
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(7):806-814.
810 times
101 times
HOU Yibing
KANG Shuo
GONG Yuan
WANG Xiaohui
NIE Ying
LIU Huanlong
Sugemalimab
Non-small cell lung cancer
Effectiveness
Safety
Economics
Rapid health technology assessment
Details
上一页
1
2
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University